CTRI/2019/04/018509已完成2 期
Clinical evaluation of Shadbindu Taila Nasya and Chitraka Haritaki in the management of Pinasa (Chronic Rhinosinusitis)
CCRAS0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of either sex with age between 18 and 60 years.
- •2.Known case of Chronic Rhinosinusitis as per American Academy of Otolaryngology- Head and Neck Surgery Foundation (AAO-HNS) criteria (Annexure I)
- •A.Twelve weeks or longer of two or more of the following signs and symptoms:
- •ï?¶mucopurulent drainage (anterior, posterior, or both), nasal obstruction (congestion),
- •ï?¶facial pain-pressure-fullness, or
- •ï?¶ Decreased sense of smell.
- •B.Inflammation is documented by one or more of the following findings:
- •ï?¶purulent (not clear) mucus or edema in the middle meatus or anterior ethmoid region,
- •ï?¶polyps in nasal cavity or the middle meatus, and/or
- •ï?¶Radiographic imaging showing inflammation of the paranasal sinuses.
- •3. Willing to give written informed consent for the participation.
排除标准
- •1.Patients below 18 and above 60 years of age.
- •2.History of chronic nasal or upper respiratory tract symptoms or disorders other than Sinusitis.
- •3.Patients suffering with tonsillitis/adenoids.
- •4.Patients who are on treatment with H1 antihistamine medication, Non-steroidal analgesics. Corticosteroids Nasal drops, Leukotriene antagonists, Nasal vasoconstrictors, or any other drugs that may have an influence on the outcome of the study.
- •5.Patients with uncontrolled Diabetes Mellitus (Blood Sugar Fasting > 250 mg/dl).
- •6.Patients with poorly controlled Hypertension ( >=160 / 100 mmHg).
- •7.Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders etc).
- •8.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •9.Symptomatic patients with clinical evidence of Heart failure.
- •10.Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL).
- •11.Alcoholics and/or drug abusers.
- •12.Pregnant women and Lactating mothers.
- •13.Patients who have completed participation in any other clinical trial during the past six months.
- •14.Any other condition which the investigator thinks may jeopardize the study.
研究者
相似试验
已完成
1 期
An Ayurvedic management of Nasal polyp with Shikhari Taila and Chitraka Haritaki AvalehaCTRI/2015/10/006311IPGT and RA61
尚未招募
2 期
Shadbindu ghrita nasya along with Pippalyadi rasayana orally in Management of Vataja PratishyayaCTRI/2024/05/067389Government Akhandanand Ayurveda College Ahmedabad
已完成
1 期
A Comparative Clinical Study of Effect of Medicated Oil Enema and Sudation Therapy in the management of Knee Joint OsteoarthritisCTRI/2019/06/019945Dr Prakash Meti105
尚未招募
3 期
A comparative clinical study of Sahacharadi oil Matra Basti (enema) Panchkarma with Tila (Sesame) oil Matra Basti (enema) in Gridhrasi (Scietica).CTRI/2019/10/021757Dr Milind Kamble
尚未招募
2 期
A study on Vataja Pratishyaya by using Anu Taila with Trikatu Churna and Vidaryadi Ghrita with Trikatu ChurnaCTRI/2022/07/043828Patanjali Ayurved Hospital